What a great first day @ictmc2026 Amazing speakers and posters. Looking forward to today with a few staff members speaking with even more poster presentations. #research #ictmc2026 #clinicaltrials
@penctu.bsky.social
@penctu.bsky.socialWhat a great first day @ictmc2026 Amazing speakers and posters. Looking forward to today with a few staff members speaking with even more poster presentations. #research #ictmc2026 #clinicaltrials
@macesari.bsky.socialPublic #consultation open!
The WHO is seeking input on how to better include underrepresented populations in #ClinicalTrials, because medical #research should reflect all of us.
Your voice matters.
Deadline: October 29, 2026
@gmj-georgia.bsky.socialResearchers publishing in Nature Medicine have established a standardized framework for immune aging biomarkers in clinical trials—a major step toward accele… #Agingresearch #Biomarkers #Clinicaltrials #GeroScience #Immuneaging #Agingresearch #Biomarkers #Clinicaltrials #GeroScience #Immuneagin…
@tickerade.bsky.social🧬 Sarepta Therapeutics $SRPT CEO Michael Severino outlined a positive outlook, highlighting improving physician engagement for ELEVIDYS and potential label expansions for ELEVIDYS and ENDEAVOR by 2027.
#clinicaltrials
@southamptonctu.bsky.socialHead of Trial Management & Methodology Lead, Jacqui Nuttall, presenting at #ICTMC2026 on our work to widen participation in #ClinicalTrials.
Through community engagement, we're co-designing an online resource to help build community-researcher relationships.
Find out more - bit.ly/diversityint...
@clinicalpainadv.bsky.socialPhase 3 trials evaluate #suzetrigine, a selective NaV1.8 inhibitor, for moderate-to-severe #acutepain.
📊 LSMD SPID48 vs. placebo:
• Abdominoplasty: 48.4 (P < .0001)
• Bunionectomy: 29.3 (P = .0002)
Read the review: https://bit.ly/4gtTE9H
@gregoryai.bsky.socialNew clinical trial
Real-World Outcomes of Ofatumumab: Relapse Rates, Disease Progression, and Treatment Patterns in Germany and Japan
@megadoctornews.comFDA Launches Expedited IND Pilot to Speed Up Clinical Trials #BigPmarma #ClinicalTrials #FastTrackClinicalTrials #MegaDoctorNews #pharma #RioGrandeValley #TrumpAdministration #USFoodAndDrugAdministrationFda https://megadoctornews.com/fda-launches-expedited-ind-pilot-to-speed-up-clinical-trials/
@innovative-ctu.bsky.social📢 Want to hear more about data-enabled trials at #ICTMC2026?
Find all the posters and presentations from the Transforming Data for Trials (#TDfT) team in one place:
🔗 www.bdi.ox.ac.uk/research/hdr...
@dhsc-answers.bsky.socialA question on #Cancer #ClinicalTrials tabled by Olly Glover on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/24968
@dhsc-answers.bsky.socialA question on #ClinicalTrials tabled by Olly Glover on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/24969
@dhsc-answers.bsky.socialA question on #PancreaticCancer #ClinicalTrials tabled by Antonia Bance on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/22293
@dhsc-answers.bsky.socialA question on #PancreaticCancer #ClinicalTrials tabled by Antonia Bance on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/22294
@eaonc.bsky.social#CancerResearch progress is not guaranteed. As the American Society of Clinical Oncology's Save Research campaign highlights, continued federal investment is critical to supporting researchers, fueling innovation, & advancing #ClinicalTrials. More: https://bit.ly/3V9APjK #SaveResearchStopCancer
@ascptclinpharm.bsky.socialStay sharp on the latest research. New consent forms can run 16 pages ~6,000 words but is longer really clearer? The newest Translational Bytes post digs into why SIS/consent length matters for trial participants. Read now: https://bit.ly/3SEubBo
#CTSjournal #ClinicalTrials
@corterve.bsky.socialBTD is not an approval of first-line combo therapy. Rasonque is FDA-approved (26 Aug) for metastatic PDAC after ≥1 prior systemic therapy, or if multiagent chemo isn't an option. The GnP combo in untreated disease is still investigational (RASolute 303). #ClinicalTrials
@proacteuresponse.bsky.socialEU-SyndAct combines an innovative platform trial design with patient involvement, looking beyond clinical outcomes to include symptoms, quality of life and patients’ experiences.
🔗 Read more: proact-response.eu/eu-syndact-a...
@situ-oxford.bsky.socialWishing all SITU members attending #ICTMC2026 a fantastic and productive conference! We hope you enjoy the inspiring sessions, valuable discussions, and networking opportunities. Good luck to all SITU poster presenters, we're sure you'll do brilliantly! 🍀 #ClinicalTrials #ResearchMethods
@innovative-ctu.bsky.socialIf you're at #ICTMC2026 this week, make sure to check out the Data-enabled trials session featuring researchers from the Transforming Data for Trials team.
🗓️ Wed 16 Sep, 3:45- 5 PM
📍 Hall 9
🔗 inconference.eventsair.com/ictmc-2026
@penctu.bsky.socialIt’s great to attend the first Keynote of the ICTMC 2026 Conference in Birmingham. We are all looking forward to the next few days. #ictmc2026 #research #clinicaltrials